Association of Plane of Total Mesorectal Excision With Prognosis of Rectal Cancer
Rattachement africain : de. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Importance: Previous retrospective studies have shown that surgical quality affects local control in rectal cancer.. Objective: In this secondary end point analysis, we evaluated the prognostic effect of the total mesorectal excision (TME) plane in the CAO/ARO/AIO-04 phase 3 randomized clinical trial. Design, Setting, and Participants: The CAO/ARO/AIO-04 trial enrolled 1236 patients with cT3-4 and/or node-positive rectal adenocarcinoma from 88 centers in Germany between July 25, 2006, and February 26, 2010. Interventions: Patients were randomized to receive treatment with standard fluorouracil-based preoperative chemoradiotherapy (CRT) alone (control arm) or oxaliplatin (experimental arm) followed by TME and adjuvant chemotherapy. Main Outcomes and Measures: The TME quality (mesorectal, intramesorectal, and muscularis propria plane) was prospectively assessed in 1152 operation specimens. An assessment was performed independently by pathologists and surgeons. The results were correlated with clinicopathologic data and the clinical outcome was tested, including multivariable analysis with the Cox regression model. Results: Of 1152 German Caucasian participants, 332 (28.8) were women and the mean age was 63 years. The plane of TME was mesorectal in 930 patients (80.7%), intramesorectal in 169 (14.7%), and muscularis propria in 53 (4.6%). In a univariable analysis, the TME plane was significantly associated with 3-year disease-free survival (mesorectal vs intramesorectal vs muscularis propria, 95% CI, 73.1-78.8 vs 61.6-76.0 vs 55.6-81.3, respectively; P = .01), cumulative incidence of local and distant recurrences (mesorectal vs intramesorectal vs muscularis propria, 95% CI, 2.0-4.5 vs 1.2-8.1 vs 2.5-20.5, respectively; P < .001; and mesorectal vs intramesorectal vs muscularis propria, 95% CI, 17.0-22.4 vs 18.3-32.0 vs 14.2-39.0, respectively; P = .03, respectively), and overall survival (mesorectal vs intramesorectal vs muscularis propria, 95% CI, 88.3-92.3 vs 79.7-91.0 vs 81.6-98.7, respectively; P = .02). In contrast to the pathologist-based evaluation, the assessment of TME plane by the operating surgeon failed to demonstrate prognostic significance for any of these clinical end points. In a multivariable analysis, the plane of surgery (mesorectal vs muscularis propria TME) constituted an independent factor for local recurrence (P = .002). Conclusions and Relevance: This phase 3 randomized clinical trial confirms the long-term clinical effect of TME plane quality on local recurrence, as initially reported in the MRC CR07 study. The data highlight the key role of pathologists and surgeons in the multidisciplinary management of rectal cancer. Trial Registration: ClinicalTrials.gov Identifier: NCT00349076.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Association of Plane of Total Mesorectal Excision With Prognosis of Rectal Cancer
- Date Crossref
- 15/08/2018
- Éditeur
- American Medical Association (AMA)
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
Universitätsmedizin Göttingen pays non établi dans la noticeÉtablissement de santé
-
Goethe University Frankfurt pays non établi dans la noticeUniversité ou école supérieure
-
University Hospital Frankfurt pays non établi dans la noticeÉtablissement de santé
-
Leipzig University pays non établi dans la noticeUniversité ou école supérieure
-
Nuremberg Hospital pays non établi dans la noticeÉtablissement de santé
-
Städtische Kliniken Mönchengladbach pays non établi dans la noticeÉtablissement de santé
-
Kliniken Maria Hilf pays non établi dans la noticeÉtablissement de santé
-
Asklepios Fachklinikum Brandenburg pays non établi dans la noticeÉtablissement de santé
-
Klinikum Oldenburg pays non établi dans la noticeÉtablissement de santé
-
Klinikum Esslingen pays non établi dans la noticeÉtablissement de santé
-
Universitätsklinikum Würzburg pays non établi dans la noticeÉtablissement de santé
-
Friedrich-Alexander-Universität Erlangen-Nürnberg pays non établi dans la noticeUniversité ou école supérieure
Universitätsmedizin Göttingen, Goethe University Frankfurt et University Hospital Frankfurt, avec 9 autres affiliations.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.